New Viability Assays for <i>Acanthamoeba castellanii</i> Trophozoites and Cysts Allow Rapid Assessment of Drug Activity

Pathogenic free-living amoebae such as Acanthamoeba castellanii are present in soil and water worldwide. A. castellanii causes systemic infections with very high mortality rates, yet drugs specifically targeting this pathogen are not available. Methods to reliably generate and assay cysts, which drive infection recurrence and drug resistance, are unavailable in a high-throughput format suitable for drug screening and testing. In this study, we developed a robust and reproducible protocol for encysting A. castellanii as well as a high-throughput, quantitative cyst viability assay using fluorescent live/dead staining coupled with microscopy and automated image analysis. These methods, coupled with optimized techniques for measuring trophozoite viability and pseudocyst formation, were used to screen the activity of 16 clinically relevant drugs and disinfectants. Four agents, including caspofungin, were active against both trophozoites and cysts.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-11-25
DOI
https://doi.org/10.1093/infdis/jiaf599
Primary Topic
Legionella and Acanthamoeba research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Viability Assays for Acanthamoeba castellanii Trophozoites and Cysts Allow Rapid Assessment of Drug Activity

Carrie A. Flynn, Barbara I. Kazmierczak, Rebecca I. Colón-Ríos, William F. Flynn et al.
The Journal of Infectious Diseases
Legionella and Acanthamoeba research
article

New Viability Assays for Acanthamoeba castellanii Trophozoites and Cysts Allow Rapid Assessment of Drug Activity

Carrie A. Flynn, Barbara I. Kazmierczak, Rebecca I. Colón-Ríos, William F. Flynn, Andrew Harmez
article en

Abstract

Pathogenic free-living amoebae such as Acanthamoeba castellanii are present in soil and water worldwide. A. castellanii causes systemic infections with very high mortality rates, yet drugs specifically targeting this pathogen are not available. Methods to reliably generate and assay cysts, which drive infection recurrence and drug resistance, are unavailable in a high-throughput format suitable for drug screening and testing. In this study, we developed a robust and reproducible protocol for encysting A. castellanii as well as a high-throughput, quantitative cyst viability assay using fluorescent live/dead staining coupled with microscopy and automated image analysis. These methods, coupled with optimized techniques for measuring trophozoite viability and pseudocyst formation, were used to screen the activity of 16 clinically relevant drugs and disinfectants. Four agents, including caspofungin, were active against both trophozoites and cysts.

The Journal of Infectious DiseasesVol. 233(3)
Yale University (US), Jackson Laboratory (US), Yale New Haven Health System (US)
Openalex Percentile: Top 68%
Legionella and Acanthamoeba research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.